Docetaxel (Taxotere) is active in non-small-cell lung cancer: a phase II trial of the EORTC Early Clinical Trials Group (ECTG)

por Cerny, T., Kaplan, S., Pavlidis, N., Schöffski, P., Epelbaum, R., van Meerbeek, J., Wanders, J., Franklin, H. R., Kaye, S.
Publicado 1994

Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers

por Golan, T, Kanji, Z S, Epelbaum, R, Devaud, N, Dagan, E, Holter, S, Aderka, D, Paluch-Shimon, S, Kaufman, B, Gershoni-Baruch, R, Hedley, D, Moore, M J, Friedman, E, Gallinger, S
Publicado 2014